Navigation Links
$1,000,000 Global B.R.A.I.N. Prize Seeks Applicants
Date:2/6/2013

TEL AVIV, Israel, February 6, 2013 /PRNewswire/ --

Israel Brain Technologies (IBT) is seeking applicants for its $1,000,000 Global B.R.A.I.N. Prize competition. Applications will be accepted until March 15, 2013.

The Global B.R.A.I.N (Breakthrough Research And Innovation in Neurotechnology) Prize is an international R&D award to be granted to an individual, group or organization for a recent breakthrough in the field of brain technology.

The one-million-dollar prize will recognize a disruptive innovation on a path to commercialization with potentially significant impact to humanity. Innovations eligible for the award include:

1. Novel technologies that can augment scientific understanding of the brain

2. New technologies for the diagnosis and treatment of brain disease

3. Cutting-edge technologies to enhance human brain function

4. Groundbreaking Brain-Machine Interface technologies

5. Innovative brain stimulation technologies

6. Disruptive brain-inspired technologies in computation, communications and robotics

The prize will be awarded at IBT's Global Brain Technology Conference to be held in October, 2013. The prize is aimed at supporting further development of the winning technology.

Full contest details, terms and conditions as well as an application form can be found here.

The international judging committee is composed of distinguished leaders in neuroscience, technology and business, including three Nobel laureates: Profs. Eric Kandel , Daniel Kahneman and Bert Sakmann .

About Israel Brain Technologies

Israel Brain Technologies (IBT), a non-profit organization, has embarked upon a mission to advance the neurotechnology industry and establish Israel as a global epicenter of brain technology and related research.

IBT promotes multi-disciplinary research and development projects in Israel as well as collaboration between the Israeli brain ecosystem and the global community of researchers and innovators.

IBT was inspired by the vision of Israeli President Shimon Peres , a leading proponent of brain research and technology.

IBT is led by a team of technology entrepreneurs and life-science professionals, and is advised by a panel of renowned academic, industry and public sector representatives including Nobel laureates.

For more information, please visit: http://www.israelbrain.org/

CONTACT:
Miri Polachek
IBT Executive Director
miri@israelbrain.org
+972-3-6441735


'/>"/>
SOURCE Israel Brain Technologies (IBT)
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Julphar Extends its Global Footprint With Official Inauguration of Julphar Ethiopia Manufacturing Facility
2. Cynosure to Participate in Leerink Swann Global Healthcare Conference 2013
3. Solta Medical to Present at the Leerink Swann Global Healthcare Conference in New York on February 14, 2013
4. Monoclonal Antibody Industry 2013 Global and China Market Analysis in New Research Report at RnRMarketResearch.com
5. Luminex Corporation To Present At Leerink Swann Global Healthcare Conference
6. CBIS Releases Corporate Operational Guidance for 2013 as the Company Reorganizes to better meet the Growing Global Crisis Associated with Anti-Retroviral Drug Resistance among People with AIDS, as well as the Increasing Need for Patient Friendly Ski
7. Virile Numbers Showing up in the Global Male Grooming Products Market, sees Kline
8. Global Markets for Spectroscopy Equipment
9. The Indian Pharmaceutical Industry 2013: Coming of Age in a Global Market
10. Global BioClinical Awarded Cancer Genome Atlas (TCGA) Contract
11. Global Spinal Nonfusion Market to Grow to $1 Billion by 2017, Despite Challenges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)...   Pairnomix, LLC, a genetic research company and ... the White House, today announced that findings from its first ... candidate therapies for a patient with epileptic encephalopathy caused by ... at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process involves ...
(Date:12/4/2016)... EAST HANOVER, N.J. , Dec. 3, 2016 /PRNewswire/ ... SEG101 (crizanlizumab, formerly SelG1), an anti-P-selectin antibody, reduced the ... by 45.3% compared to placebo (1.63 vs 2.98, p=0.010) ... Novartis today announced that the data are being featured ... American Society of Hematology (ASH) Annual Meeting and ...
(Date:12/4/2016)... Dec. 3, 2016  Findings from a Novartis ... CTL019, an investigational chimeric antigen receptor T cell ... young adult patients with B-cell acute lymphoblastic leukemia ... session at the 58th American Society of Hematology ... p.m.). The global Phase II study found that ...
Breaking Medicine Technology:
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation ... research and serving the lymphoma community through a comprehensive series of education programs, ... Event in New York City, with long-time partners The Paul Foundation, on November ...
(Date:12/4/2016)... Aliso Viejo, California (PRWEB) , ... December 04, ... ... self-animating lower third presets that have new attractive animation styles with unique displacement ... Pro3rd Displace features 30 pre-animated lower third designs. Choose from a variety of ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Lori G. ... Traurig, LLP’s Atlanta office, will speak at the American Conference Institute’s 21st Drug ... Traurig is also a Lead Sponsor of the conference. , Cohen, who chairs the ...
(Date:12/2/2016)... ... December 02, 2016 , ... Advanced Inc., a leading provider of ... Bice, CPA, MBA to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, ... Jason brings extensive financial and operational leadership experience to Advanced Inc. He began his ...
(Date:12/2/2016)... PA (PRWEB) , ... December 02, 2016 , ... With ... struggling through rehabilitation of an injury, patients must find the one that works for ... his pain, he created a machine that worked and decided to share it with ...
Breaking Medicine News(10 mins):